SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

The SARS-CoV-2 virus elicits humoral immune responses with the production of IgG, IgM and IgA isotypes. Different isotypes may predominate at different times post-infection. IgM and IgA isotypes ...

Today in BMC Medicine, researchers in Catalonia, Spain, estimate that 23% of adult COVID-19 survivors develop long COVID, ...

SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.

SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations ...

According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. Long ...

The virus that causes COVID-19 has been very good at mutating to keep infecting people—so good that most antibody treatments ...

To verify the ELISpot data, they cultivated ASCs in vitro and assessed IgG specific for Flu, Tet, and SARS-CoV-2 spike ...

Scientists found that the new virus can bind to human ACE2, making it similar to SARS-CoV-2 and NL63 (a common cold virus). The new virus called HKU5-CoV-2, discovered in bats in China ...

SARS-CoV-2 between 2021 and 2023 developed long-COVID, and in more than half of them the symptoms persisted for two years.